However the new hep C drugs have not only transformed treatment of the disease; they have also changed forever the conversation around how drugs can be paid for. The HCV drugs are unusual in ...
Hepatitis C campaigners and pharma companies ... but pharma companies will be hoping the new expansion of treatment will be a win for them as well as patients. Pfizer's Braftovi - just approved ...
The objectives of this review are to highlight the improvements that have been made in the current treatment of autoimmune hepatitis and to indicate the progress toward new therapies that justify ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).
with resolution of chronic hepatitis in about half of patients. Regrettably there are few treatment options for those patients who do not have a sustained virologic response. Although some new ...